Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance

被引:35
作者
Caws, M [1 ]
Drobniewski, FA [1 ]
机构
[1] Kings Coll Hosp Dulwich, Guys Kings & St Thomas Sch Med, PHLS Mycobacterium Reference Unit, London SE22 8QF, England
来源
NEW VISTAS IN THERAPEUTICS, FROM DRUG DESIGN TO GENE THERAPY: DRUG-RESISTANT TUBERCULOSIS, FROM MOLECULES TO MACRO-ECONOMICS | 2001年 / 953卷
关键词
Mycobacterium tuberculosis; drug resistance; multidrug-resistant tuberculosis; TB microbiology;
D O I
10.1111/j.1749-6632.2001.tb11371.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Early diagnosis of Mycobacterium tuberculosis disease is crucial in initiating treatment and interrupting the train of transmission. The increasing incidence of MDR TB worldwide has also placed emphasis on the need for early detection of drug resistance, particularly to isoniazid and rifampicin. Molecular diagnostic techniques and automated culture systems have reduced turnaround times in the modern mycobacteriology laboratory, and the continuing evaluation and development of such techniques is increasing the use of molecular technology in developed nations. Simple phenotypic methods for the detection of resistance to first-line drugs and genotypic kit-form assays for detection of rifampicin resistance have been developed that have become key tools in the containment of MDR TB.
引用
收藏
页码:138 / 145
页数:8
相关论文
共 35 条
[1]   Role of embB in natural and acquired resistance to ethambutol in mycobacteria [J].
Alcaide, F ;
Pfyffer, GE ;
Telenti, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2270-2273
[2]   Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis [J].
Bergmann, JS ;
Keating, WE ;
Woods, GL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :863-865
[3]   Detection of rifampin- and ciprofloxacin-resistant Mycobacterium tuberculosis by using species-specific assays for precursor rRNA [J].
Cangelosi, GA ;
Brabant, WH ;
Britschgi, TB ;
Wallis, CK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1790-1795
[4]  
Carriere C, 1997, J CLIN MICROBIOL, V35, P3232
[5]   HIV associated tuberculosis - A barometer for wider tuberculosis control and prevention [J].
Coker, R ;
Miller, R .
BRITISH MEDICAL JOURNAL, 1997, 314 (7098) :1847-1847
[6]   The mycobacteriology milestones - Journeying to the new millennium [J].
Della-Latta, P .
LABORATORY MEDICINE, 1999, 30 (06) :408-417
[7]  
DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213
[8]   Epidemiology of tuberculosis in the world [J].
Drobniewski, F ;
PablosMendez, A ;
Raviglione, MC .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 18 (05) :419-429
[9]  
Drobniewski FA, 2000, J CLIN MICROBIOL, V38, P444
[10]   A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis [J].
Drobniewski, FA ;
Watterson, SA ;
Wilson, SM ;
Harris, GS .
JOURNAL OF MEDICAL MICROBIOLOGY, 2000, 49 (03) :271-278